EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY 4.0

Quality of life, bowel dysfunction, and long-term oncological outcomes after transanal versus laparoscopic total mesorectal excision for mid- and low- rectal cancer (Ta-LaTME study): multicentre randomized open-label trial

Xavier Serra-Aracil iD, Anna Gonzalez, Josep Bargalló, Anna Serracant, Jordi Roura, Ladislao Cayetano-Paniagua, Salvadora Delgado, Alba Zarate, Ta-LaTME Study Group

BJS Open · 03.07.2026 · 10 (4)

DOI: 10.1093/bjsopen/zrag045 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift BJS Open, online erschienen am 04.08.2026. Verfasst von Xavier Serra-Aracil und 8 weiteren Autor:innen. Beteiligte Einrichtung: Coloproctology Unit, Parc Taulí University Hospital, Sabadell, Spain. Hauptthemen laut MEDLINE: Rectal Neoplasms, Quality of Life, Laparoscopy, Adenocarcinoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Societat Catalana de Cirurgia, Institut d'investigació i innovació Parc Taulí, IDCSALUD.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Quality of life (QoL) and bowel function are key outcomes in mid- and low rectal cancer. The comparative impact of laparoscopic total mesorectal excision (LaTME) versus transanal total mesorectal excision (TaTME) on patient-reported outcomes and long-term oncological results in randomized trials remains unclear.

Methods

This prospective multicentre randomized trial enrolled patients with resectable mid–low rectal adenocarcinoma. QoL was assessed using the 30- and 29-item European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaires EORTC QLQ-C30 and QLQ-CR29, respectively) and bowel dysfunction was assessed using the Low Anterior Resection Syndrome (LARS) score before surgery and at the long-term follow-up (≥ 12 months after index surgery). The sample size calculation was based on the primary endpoint from the original randomized clinical trial (composite conversion outcome), for which 116 patients were required. The minimum oncological follow-up was 5 years. Modified intention-to-treat (mITT) and per-protocol analyses were prespecified.

Results

In all, 116 patients were randomized (LaTME, 57; TaTME, 59); 105 patients were included in the mITT analysis. Sixty-seven valid QoL questionnaires were obtained (63.8%). Postoperative global health status (EORTC QLQ-C30) was high in both groups (median score 83.3) with no significant differences between them, and functional scales remained near maximum, with improved emotional functioning after LaTME only. Using the EORTC QLQ-CR29 score, TaTME showed higher postoperative stool frequency, flatulence, and faecal incontinence, with similar body image and sexual function. LARS scores (assessed only in patients without a permanent stoma) were comparable between LaTME and TaTME (median 24 versus 27, respectively), with major LARS (score 30–42) in 30 and 44% of LaTME and TaTME patients respectively. There were no significant differences between LaTME and TaTME in local recurrence (6.4% versus 3.7%, respectively), distant recurrence (14.9% versus 18.5%, respectively), disease-free survival, and overall survival.

Conclusion

Overall QoL and bowel function remained high, with no detectable between-group differences. TaTME was associated with a higher burden of specific evacuatory symptoms on the EORTC QLQ-CR29. Long-term oncological outcomes did not differ significantly between techniques. Registration number: NCT02550769 (http://www.clinicaltrials.gov).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rectal NeoplasmsQuality of LifeLaparoscopyAdenocarcinomaProctectomyTransanal Endoscopic SurgeryHumansFemaleMaleAgedLow Anterior Resection SyndromeMiddle AgedProspective StudiesTreatment OutcomePostoperative ComplicationsFecal IncontinenceSurveys and QuestionnairesPatient Reported Outcome Measures

Stichwörter der Autor:innen

bowel functionlow anterior resection syndromeoncological safetypatient-reported outcome measures (PROMs)randomized clinical trial

Autor:innen und Institutionen

  • Coloproctology Unit, Parc Taulí University Hospital, Sabadell, Spain.
  • Department of Surgery, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • General and Digestive Surgery Department, Hospital Consorcio Sanitario Terrassa, Terrassa, Spain.
  • General and Digestive Surgery Department, Hospital General de Catalunya, Barcelona, Spain.
  • Coloproctology Unit, General and Digestive Surgery Department, Hospital Universitario Mutua de Terrassa, Terrassa, Spain.
  • General and Digestive Surgery Department, Germans Trias I Pujol University Hospital, Badalona, Spain.

ORCID-Profile: Xavier Serra-Aracil

Förderung

  • Societat Catalana de Cirurgia
  • Institut d'investigació i innovació Parc Taulí
  • IDCSALUD
  • Hospital General de Catalunya
  • Institut d’investigació i innovació Parc Taulí

Zitieren

APA

Serra-Aracil, X., Gonzalez, A., Bargalló, J., Serracant, A., Roura, J., Cayetano-Paniagua, L., Delgado, S., Zarate, A., & Ta-LaTME Study Group (2026). Quality of life, bowel dysfunction, and long-term oncological outcomes after transanal versus laparoscopic total mesorectal excision for mid- and low- rectal cancer (Ta-LaTME study): multicentre randomized open-label trial. BJS Open, 10(4). https://doi.org/10.1093/bjsopen/zrag045

Vancouver

Serra-Aracil X, Gonzalez A, Bargalló J, Serracant A, Roura J, Cayetano-Paniagua L, et al. Quality of life, bowel dysfunction, and long-term oncological outcomes after transanal versus laparoscopic total mesorectal excision for mid- and low- rectal cancer (Ta-LaTME study): multicentre randomized open-label trial. BJS Open. 2026;10(4). doi:10.1093/bjsopen/zrag045

BibTeX
@article{SerraAracil2026,
  author = {Serra-Aracil, Xavier and Gonzalez, Anna and Bargalló, Josep and Serracant, Anna and Roura, Jordi and Cayetano-Paniagua, Ladislao and Delgado, Salvadora and Zarate, Alba and Ta-LaTME Study Group, Ta-LaTME Study Group},
  title = {Quality of life, bowel dysfunction, and long-term oncological outcomes after transanal versus laparoscopic total mesorectal excision for mid- and low- rectal cancer (Ta-LaTME study): multicentre randomized open-label trial},
  journal = {BJS Open},
  year = {2026},
  volume = {10},
  number = {4},
  doi = {10.1093/bjsopen/zrag045}
}
Kostenlos starten →